Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology
Overview
The study is designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical assessments and BNA scores. The results are primarily intended for scientific inquiry and engineering development purposes, and may be used in future regulatory submissions.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: January 1, 2023
Detailed Description
A multi-center study in which subjects that had completed or are completing a BNA test with the Auditory Oddball task (or other tests that will be commercially cleared at any given time), will have the option to complete additional investigational tasks and optional clinical assessments and questionnaire forms. At each site, these additional assessments will be suggested by the site's study doctor or clinician and will be collected with the site's ePRO device. The study will include up to 10,000 subjects which had completed or will complete a standard BNA test. Authorized personnel will offer the subjects to participate in the study immediately after testing or contacting subjects that had completed the test in the past. Procedure of consent will be performed by the PI or delegates.
Interventions
- Device: Brain Network Activation (BNA™) technology
- The BNA™ technology was developed and is utilized by ElMindA Ltd. The BNA Analysis System is cleared for use by qualified medical professionals for the post hoc statistical analysis of the human electroencephalogram (“EEG”), utilizing evoked response potentials (“ERP’). This device is indicated for use in individuals 14 to 24 years of age. The BNA Analysis System is to be used with the auditory oddball task only.
Arms, Groups and Cohorts
- Subject who completed or will complete a BNA test
Clinical Trial Outcome Measures
Primary Measures
- Engineering development according to clinical assessments
- Time Frame: 5 years
- The study is designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical assessments and BNA scores. The results are primarily intended for scientific inquiry and engineering development purposes, and may be used in future regulatory submissions.
Participating in This Clinical Trial
Inclusion Criteria
- Completed or will complete a BNA test – Able to speak, read and understand English sufficiently to understand the nature of the study, and to allow completion of all study assessments. – Willingness to participate Exclusion Criteria:
Gender Eligibility: All
Minimum Age: 8 Years
Maximum Age: 99 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- ElMindA Ltd
- Provider of Information About this Clinical Study
- Sponsor
- Overall Contact(s)
- Liran Korine, +972-9-9516476, Liran@elminda.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.